Mary N. Brown

Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, in patients with asthma: a phase 2a randomized, double blind, placebo-controlled crossover trial

J. Beier, Ulrika Wählby Hamrén, R. Fuhr, 2019, Respiratory Research.

The absolute risk of incident type 2 diabetes following exposure to systemic corticosteroids in selected steroid‐related and phenotypic groups

P. Hunt, C. Currie, E. Berni, 2022, Diabetes, obesity & metabolism.

The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial

B. Make, S. Rennard, K. Pardali, 2018, International journal of chronic obstructive pulmonary disease.

The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial

Steven, B. Make, S. Rennard, 2018, International journal of chronic obstructive pulmonary disease.

Seven Pillars of Small Airways Disease in Asthma and COPD - Supporting Opportunities for Novel Therapies.

S. Rennard, O. Usmani, J. Hjoberg, 2021, Chest.